Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 May 2020
Historique:
received: 03 04 2020
revised: 05 05 2020
accepted: 06 05 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 11 2 2021
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especially, the development of fibrosis and portal hypertension in NAFLD patients requires treatment. Transgenic TGR(mREN2)27 rats overexpressing mouse renin spontaneously develop NAFLD with portal hypertension but without obesity. This study investigated the additional role of obesity in this model on the development of portal hypertension and fibrosis. Obesity was induced in twelve-week old TGR(mREN2)27 rats after receiving Western diet (WD) for two or four weeks. Liver fibrosis was assessed using standard techniques. Hepatic expression of transforming growth factor-β1 (TGF-β1), collagen type Iα1, α-smooth muscle actin, and the macrophage markers Emr1, as well as the chemoattractant Ccl2, interleukin-1β (IL1β) and tumor necrosis factor-α (TNFα) were analyzed. Assessment of portal and systemic hemodynamics was performed using the colored microsphere technique. As expected, WD induced obesity and liver fibrosis as confirmed by Sirius Red and Oil Red O staining. The expression of the monocyte-macrophage markers, Emr1, Ccl2, IL1β and TNFα were increased during feeding of WD, indicating infiltration of macrophages into the liver, even though this increase was statistically not significant for the EGF module-containing mucin-like receptor (Emr1) mRNA expression levels. Of note, portal pressure increased with the duration of WD compared to animals that received a normal chow. Besides obesity, WD feeding increased systemic vascular resistance reflecting systemic endothelial and splanchnic vascular dysfunction. We conclude that transgenic TGR(mREN2)27 rats are a suitable model to investigate NAFLD development with liver fibrosis and portal hypertension. Tendency towards elevated expression of Emr1 is associated with macrophage activity point to a significant role of macrophages in NAFLD pathogenesis, probably due to a shift of the renin-angiotensin system towards a higher activation of the classical pathway. The hepatic injury induced by WD in TGR(mREN2)27 rats is suitable to evaluate different stages of fibrosis and portal hypertension in NAFLD with obesity.

Identifiants

pubmed: 32392802
pii: ijms21093308
doi: 10.3390/ijms21093308
pmc: PMC7246932
pii:
doi:

Substances chimiques

Adgre1 protein, rat 0
Ccl2 protein, rat 0
Chemokine CCL2 0
Receptor, Angiotensin, Type 1 0
Receptors, Cell Surface 0
Ren2 protein, mouse 0
Transforming Growth Factor beta 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Renin EC 3.4.23.15

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB TRR57
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1382
Organisme : Horizon 2020
ID : 668031
Organisme : Horizon 2020
ID : 825694
Organisme : Horizon 2020
ID : 731875

Références

Results Probl Cell Differ. 2017;62:161-179
pubmed: 28455709
Lab Invest. 2018 Oct;98(10):1263-1275
pubmed: 29326427
Liver Int. 2020 Feb;40 Suppl 1:72-76
pubmed: 32077608
Gut. 2012 Mar;61(3):416-26
pubmed: 21813474
Cell. 2018 Jan 11;172(1-2):162-175.e14
pubmed: 29328911
Sci Rep. 2015 Aug 11;5:12931
pubmed: 26263022
Liver Int. 2011 Jul;31(6):860-70
pubmed: 21645218
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Trans Assoc Am Physicians. 1992;105:123-32
pubmed: 1308989
Hepatology. 2018 Apr;67(4):1270-1283
pubmed: 28940700
Nature. 2012 Feb 01;482(7384):179-85
pubmed: 22297845
F1000Res. 2018 Jun 27;7:
pubmed: 30002817
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40
pubmed: 24768810
J Hepatol. 2000;32(1 Suppl):141-56
pubmed: 10728801
Lab Anim. 2015 Apr;49(1 Suppl):47-58
pubmed: 25835738
Dig Dis Sci. 2018 Mar;63(3):563-576
pubmed: 29368124
J Hepatol. 2008 Sep;49(3):417-28
pubmed: 18486983
J Leukoc Biol. 2007 Jul;82(1):16-32
pubmed: 17456803
Gut. 2004 May;53(5):744-9
pubmed: 15082595
Hepatology. 2009 Jul;50(1):185-97
pubmed: 19441102
Dig Dis Sci. 2016 Jul;61(7):2102-7
pubmed: 26993824
JHEP Rep. 2019 Feb 23;1(1):30-43
pubmed: 32149275
Gut. 2017 Jan;66(1):145-155
pubmed: 26385087
Gut. 2017 Jan;66(1):180-190
pubmed: 27646933
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G147-56
pubmed: 19056767
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Front Immunol. 2018 Sep 07;9:1930
pubmed: 30245686
Hepatology. 2011 Aug;54(2):555-61
pubmed: 21567436
Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1143-1152
pubmed: 30261763
J Hepatol. 2008 Oct;49(4):595-9
pubmed: 18662837
Hepatology. 2017 Apr;65(4):1293-1305
pubmed: 27997989
Nature. 1990 Apr 5;344(6266):541-4
pubmed: 2181319
Hypertension. 1991 Oct;18(4):446-57
pubmed: 1916990
Clin Gastroenterol Hepatol. 2012 Sep;10(9):1028-33.e2
pubmed: 22610002
World J Gastroenterol. 2011 Aug 7;17(29):3377-89
pubmed: 21876630
Methods Mol Biol. 2017;1627:91-116
pubmed: 28836197
Hepatology. 2008 Apr;47(4):1264-76
pubmed: 18318439
Gastroenterology. 2004 Feb;126(2):529-40
pubmed: 14762790
Sci Rep. 2019 Aug 12;9(1):11598
pubmed: 31406138
J Hepatol. 2010 Oct;53(4):702-12
pubmed: 20633948
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
F1000Prime Rep. 2014 Oct 01;6:95
pubmed: 25374673
Front Immunol. 2018 Oct 01;9:2246
pubmed: 30327653
J Hepatol. 2015 Sep;63(3):743-52
pubmed: 26047908
Hepatology. 2014 Jul;60(1):334-48
pubmed: 24619965
Eur J Immunol. 1981 Oct;11(10):805-15
pubmed: 7308288

Auteurs

Carla Cremonese (C)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Robert Schierwagen (R)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Frank Erhard Uschner (FE)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Sandra Torres (S)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Olaf Tyc (O)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Cristina Ortiz (C)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Martin Schulz (M)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Alexander Queck (A)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Glen Kristiansen (G)

Institute for Pathology, University of Bonn, 53127 Bonn, Germany.

Michael Bader (M)

Max Delbrück Center for Molecular Medicine, 13092 Berlin, Germany.

Tilman Sauerbruch (T)

Department of Internal Medicine I, University Hospital of Bonn, 53127 Bonn, Germany.

Ralf Weiskirchen (R)

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, 52074 Aachen, Germany.

Thomas Walther (T)

Department of Pharmacology and Therapeutics, University College Cork, T12 YN60 Cork, Ireland.
Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, 17489 Greifswald, Germany.

Jonel Trebicka (J)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.
Institute for Bioengineering of Catalonia, 08028 Barcelona, Spain.
European Foundation for the Study of Chronic Liver Failure, 08021 Barcelona, Spain.
Faculty of Health Sciences, University of Southern Denmark, 5000 Odense, Denmark.

Sabine Klein (S)

Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany.

Articles similaires

Humans Meals Time Factors Female Adult
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH